Sign Up Today and Learn More About ProVerum Medical Stock
Invest in or calculate the value of your shares in ProVerum Medical or other pre-IPO companies through EquityZen's platform.
ProVerum Medical Stock
ProVerum Medical is a medtech company that develops novel minimally invasive devices to treat benign prostatic hyperplasia.
About ProVerum Medical Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
ProVerum Medical Press Mentions
Stay in the know about the latest news on ProVerum Medical
Investors Are Flocking To Fund Incontinence-Focused Startups
news • Aug 29, 2025
Irish MedTech startup ProVerum raises €68.6 million to advance new treatment for urological conditions
eu-startups • Aug 26, 2025
ProVerum Secures $80 Million Series B Financing to Advance New Treatment for BPH
morningstar • Aug 25, 2025
ProVerum Secures $80 Million Series B Financing to Advance New Treatment for BPH
prnewswire • Aug 25, 2025
ProVerum Secures $80 Million Series B Financing to Advance New Treatment for BPH
biospace • Aug 25, 2025
ProVerum Medical Management
Leadership team at ProVerum Medical
CEO
Paul Bateman
Co-Founder and CSO
Conor Harkin
Join now and verify your accreditation status to gain access to:
- ProVerum Medical Current Valuation
- ProVerum Medical Stock Price
- ProVerum Medical Management
- Available deals in ProVerum Medical and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- ProVerum Medical Cap Table and Funding History by Share Class and Liquidity Preferences
- ProVerum Medical Revenue and Financials
- ProVerum Medical Highlights
- ProVerum Medical Business Model
- ProVerum Medical Risk Factors
- ProVerum Medical Research Report from SACRA Research
Trading ProVerum Medical Stock
How to invest in ProVerum Medical stock?
Accredited investors can buy pre-IPO stock in companies like ProVerum Medical through EquityZen funds. These investments are made available by existing ProVerum Medical shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ProVerum Medical stock?
Shareholders can sell their ProVerum Medical stock through EquityZen's private company marketplace. EquityZen's network includes over 400K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 49K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."